Skip to main content
SpringerLink
Log in

Anxiolytic and Antidepressant Actions of Emoxypine, Reamberin, and Mexidol in Experimental Diabetes Mellitus

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objectives. To conduct a comparative study of the anxiolytic and antidepressant activities of derivatives of 3-hydroxypyridine and succinic acid (emoxypine, Reamberin, and Mexidol) in experimental diabetes mellitus (DM). Materials and methods. The effects of emoxypine, Reamberin, and Mexidol on the signs of anxiety in an elevated plus maze and the duration of “despair” behavior in the Porsolt test were assessed in rats with alloxan diabetes during courses of drug treatment. The reference agent was α-lipoic acid. An additional series of experiments was run to study the effects of emoxypine, Reamberin, Mexidol and α-lipoic acid on the severity of hyperglycemia in experimental DM. Results and conclusions. All study drugs were used at doses equivalent to the human therapeutic range for 14 days and significantly decreased the signs of anxiety and depression in rats with alloxan diabetes. The most marked anxiolytic potential was demonstrated for emoxypine, which was the only one of the study drugs decreasing the signs of anxiety not only in comparison with the alloxan diabetes control group, but also relative to the intact control group. Derivatives of 3-hydroxypyridine and succinic acid were no less effective than α-lipoic acid in terms of the level of tranquilizing activity and were more effective than α-lipoic acid in terms of thymoanaleptic activity when given at the maximal dose to rats with experimental DM. Emoxypine and Mexidol, and also α-lipoic acid, significantly decreased hyperglycemia in alloxan diabetes at all the doses tested. Reamberin displayed only minor trends in this direction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. I. A. Volchegorskii, N. V. Mester, and O. G. Zotova, “Predictors of diabetic encephalopathy,” Zh. Nevrol. Psikhiat., 106, No. 9, 12–16 (2006).

    CAS  Google Scholar 

  2. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Dynamics of the initial signs of experimental diabetic encephalopathy,” Ros. Fiziol. Zh., 99, No. 4, 491–500 (2013).

    CAS  Google Scholar 

  3. I. A. Volchegorskii and N. V. Mester, “Effects of antioxidants of the 3-hydroxypyridine group on depression in patients with diabetes mellitus,” Klin. Med., 2, 40–45 (2007).

    Google Scholar 

  4. R. S. McIntyre, J. K. Soczynska, J. Z. Konarski, and S. H. Kennedy, “The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms,” Expert Opin. Drug Saf., 5, 157–168 (2006), doi: https://doi.org/10.1517/14740338.5.1.157.

    Article  CAS  PubMed  Google Scholar 

  5. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “The insulin-potentiating activity of antioxidants in experimental diabetes mellitus,” Prob. Endokrinol., 56, No. 2, 27–35 (2010).

    Article  CAS  Google Scholar 

  6. I. A. Volchegorskii, L. M. Rassokhina, I. Yu. Miroshnichenko, et al., “Effects of prooxidants on insulin sensitivity and glucose tolerance,” Byull. Eksperim. Biol. Med., 150, No. 9, 295–301 (2010).

    Google Scholar 

  7. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Antihypoxic actions of derivatives of 3-hydroxypyridine and succinic acid and their nootropic effects in alloxan diabetes,” Eksperim. Klin. Farmakol., 74, No. 12, 27–32 (2011).

    CAS  Google Scholar 

  8. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Effects of derivatives of 3-hydroxypyridine and succinic acid on the resistance to acute cerebral ischemia in experimental studies,” Zh. Nevrol. Psikhiat., 114, 12:123–127 (2014).

    Article  CAS  Google Scholar 

  9. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Cerebroprotective actions of derivatives of 3-hydroxypyridine and succinic acid in experimental diabetes mellitus,” Zh. Nevrol. Psikhiat., 113, 6:50–61 (2013).

    CAS  Google Scholar 

  10. I. A. Volchegorskii, M. G. Moskvicheva, and E. N. Chashchina, “Effects of antioxidants on sensorimotor polyneuropathy and affective disorders in diabetes mellitus,” Zh. Nevrol. Psikhiat., 105, No. 2, 41–45 (2005).

    CAS  Google Scholar 

  11. A. N. Mironov (ed.), Guidelines for Preclinical Studies of Medicines, Grif i K Press, Moscow (2012).

    Google Scholar 

  12. I. A. Volchegorskii, I. I. Dolgushin, O. L. Kolesnikov, and V. E. Tseilikman, Experimental Modeling and Laboratory Assessment of the Adaptive Reactions of the Body, Chelyabinsk State Pedagogical University Press (2000).

  13. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Antioxidants in experimental diabetes mellitus,” Prob. Endokrinol., 54, No. 5, 43–50 (2008).

    Google Scholar 

  14. I. A. Volchegorskii, L. M. Rassokhina, and I. Yu. Miroshnichenko, “Cerebroprotective effects of emoxypine, Reamberin, and Mexidol in alloxan diabetes,” Byull. Eksperim. Biol. Med., 155, No. 1, 63–70 (2013), doi: https://doi.org/10.1007/s10517-013-2079-3.

    Article  CAS  Google Scholar 

  15. A. Loche, F. Simonetti, C. Lobina, M. A. M. Carai, G. Colombo, M. P. Castelli, D. Barone, and R. Cacciaglia, “Anti-alcohol and anxiolytic properties of a new chemical entity, GET73,” Front. Psychiatry, 3, 1–15 (2012), doi: https://doi.org/10.3389/fpsyt.2012.00008.

    Article  CAS  Google Scholar 

  16. A. A. Walf and C. A. Frye, “The use of the elevated plus maze as an assay of anxiety-related behavior in rodents,” Nat. Protoc., 2, No. 2, 322–328 (2007), doi: https://doi.org/10.1038/nprot.2007.44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. J. J. Buccafusco, Methods of Behavioral Analysis in Neuroscience, CRC Press, London, New York (2009).

    Google Scholar 

  18. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Anxiolytic and antidepressant actions of derivatives of 3-hyroxypyridine and succinic acid in alloxan diabetes,” Ros. Fiziol. Zh., 101, No. 3, 258–267 (2015), doi: https://doi.org/10.1007/s11055-016-0287-9.

    Article  CAS  Google Scholar 

  19. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Anxiolytic and antidepressant actions of derivatives of 3-hydyroxy-pyridine and succinic acid in the acute phase of alloxan diabetes in rats,” Eksperim. Klin. Farmakol., 77, No. 4, 14–20 (2014).

    CAS  Google Scholar 

  20. I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, et al., “Comparative analysis of the activities of derivatives of 3-hydroxypyridine and succinic acid,” Byull. Eksperim. Biol. Med., 158, No. 6, 756–761 (2015), doi: https://doi.org/10.1007/s10517-015-2855-3.

    Article  CAS  Google Scholar 

  21. S. W. Chen, Q. Xin, W. X. Kong, L. Min, and J. F. Li, “Anxiolytic-like effect of succinic acid in mice,” Life Sci., 73, No. 25, 257–3264 (2003), doi: https://doi.org/10.1016/j.lfs.2003.06.017.

    Article  CAS  Google Scholar 

  22. I. A. Volchegorskii, M. N. Alekseev, M. I. Volchegorskaya, and L. M. Rassokhina, “Effects of α-lipoic acid and Mexidol on neurological and affective status in patients in the early stages of diabetic foot syndrome,” Klin. Med., 10, 52–59 (2008).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, South Ural State Medical University, Russian Federation Ministry of Health, Chelyabinsk, Russia

    I. A. Volchegorskii, I. Yu. Miroshnichenko, L. M. Rassokhina, R. M. Faizullin & K. E. Pryakhina

Authors
  1. I. A. Volchegorskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Yu. Miroshnichenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. M. Rassokhina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. M. Faizullin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. E. Pryakhina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. A. Volchegorskii.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 5, Iss. 1, pp. 52–57, May, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Volchegorskii, I.A., Miroshnichenko, I.Y., Rassokhina, L.M. et al. Anxiolytic and Antidepressant Actions of Emoxypine, Reamberin, and Mexidol in Experimental Diabetes Mellitus. Neurosci Behav Physi 49, 136–141 (2019). https://doi.org/10.1007/s11055-018-0706-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-018-0706-1

Keywords

Search

Navigation